Business description
Sandoz is a global leader in off-patent medicines, with the purpose to pioneer access for patients.
Management board & Supervisory board
| CEO |
| Richard Saynor |
| Management board |
| Colin Bond |
| Supervisory board |
| Gilbert Ghostine, Dr. Karen J. Huebscher, Maria Varsellona, Urs Riedener, Dr. Shamiram R. Feinglass, Aarti Shah, PhD, Yannis Skoufalos, Remco Steenbergen |
Company data
| Name: |
Sandoz Group N |
| Address: |
Forum 1 Novartis Campus CH-4056,Basel |
| Phone: |
+41 61 324 11 11 |
| Fax: |
+41 61 324 11 11 |
| E-mail: |
-
|
| Internet: |
https://www.sandoz.com/ |
| Industry: |
Healthcare |
| Sector: |
Pharmaceutical Industry |
| Sub sector: |
Pharmaceuticals |
| End of financial year: |
12/31 |
| Free Float: |
- |
| IPO date: |
10/4/2023 |
